The knockdown of TXNDC12 resulted in an imbalance in the oxidation-reduction dynamics within GBM cells, indicative of increased oxidative stress, which can hinder cell proliferation and potentially lead to cell death [103]. This evidence concerns the gene TXNDC12 and glioblastoma.